Fulcrum Equity Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,300
Closed -$215K 106
2025
Q1
$215K Sell
2,300
-603
-21% -$54K 0.24% 89
2024
Q4
$264K Sell
2,903
-2,377
-45% -$227K 0.26% 87
2024
Q3
$548K Buy
5,280
+153
+3% +$15.6K 0.46% 72
2024
Q2
$498K Buy
5,127
+444
+9% +$41K 0.45% 75
2024
Q1
$422K Buy
4,683
+424
+10% +$35.9K 0.5% 67
2023
Q4
$339K Buy
4,259
+146
+4% +$11K 0.42% 66
2023
Q3
$292K Buy
4,113
+10
+0.2% +$748 0.34% 71
2023
Q2
$316K Buy
+4,103
New +$318K 0.37% 72
2022
Q1
Sell
-3,192
Closed -$272K 121
2021
Q4
$272K Sell
3,192
-90
-3% -$7.03K 0.1% 144
2021
Q3
$248K Buy
3,282
+18
+0.6% +$1.43K 0.1% 151
2021
Q2
$266K Buy
3,264
+250
+8% +$20.4K 0.1% 159
2021
Q1
$238K Sell
3,014
-9
-0.3% -$705 0.09% 156
2020
Q4
$259K Sell
3,023
-354
-10% -$29.3K 0.1% 137
2020
Q3
$261K Sell
3,377
-3,958
-54% -$302K 0.12% 125
2020
Q2
$537K Buy
+7,335
New +$521K 0.25% 67

Other funds holding CL

Fulcrum Equity Management's CL Position: Q2 2025 in Review

Fulcrum Equity Management sold out of Colgate-Palmolive (CL) in Q2 2025, closing a stake of 2,300 shares — an estimated $215K sold.

Fulcrum Equity Management first reported a position in CL in Q2 2020 and held it in 15 quarters. The position peaked at $548K in Q3 2024. 1,913 funds tracked by Wall St. Rank hold CL as of Q2 2025.

  • Fulcrum Equity Management reported no remaining Colgate-Palmolive position as of Q2 2025 after selling out during the quarter.
  • Fulcrum Equity Management sold 2,300 Colgate-Palmolive shares in Q2 2025, an estimated $215K.
  • Fulcrum Equity Management first reported a position in Colgate-Palmolive in Q2 2020 and held it in 15 quarters.
  • Fulcrum Equity Management's Colgate-Palmolive position peaked at $548K in Q3 2024.
  • 1,913 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2025.

Based on Fulcrum Equity Management's 13F filing for Q2 2025, filed 25 Aug 2025.